Michio Ogano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michio Ogano has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
Jun Tanabe
14 shared publicationsWataru Shimizu
Department of Cardiovascular Medicine Nippon Medical School Bunkyō Tokyo Japan
9 shared publicationsYu-Ki Iwasaki
6 shared publications- Yu-Ki Iwasaki
Department of Cardiovascular Medicine Nippon Medical School Hospital Bunkyo‐ku Tokyo Japan
6 shared publications Kei Kimura
5 shared publicationsHisato Takagi
Department of Cardiovascular Surgery, Shizuoka Medical Center, 762-1 Nagasawa, Shimizu, Sunto Shizuoka 4110906, Japan
4 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Elsevier in Heart Rhythm
Atrial Leadless Pacemaker Implantation at the Superior Right Atrial Site
- 31 October 2026
- Published by Elsevier in Heart Rhythm
Open AccessAtrial Leadless Pacemaker Implantation at the Superior Right Atrial Site
- Open Access
- 30 October 2026
- Published by Elsevier in JACC: Asia
Conduction System Pacing for Cardiac Resynchronization Therapy
- 30 October 2026
- Published by Elsevier in JACC: Asia
Open AccessConduction System Pacing for Cardiac Resynchronization Therapy
- Open Access
- 30 January 2026
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (9) , 1017-1022
Perisinus nodal atrial pacing at the right anterosuperior site using a leadless atrial pacemaker: A case series
- 30 January 2026
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (9) , 1017-1022
Open AccessPerisinus nodal atrial pacing at the right anterosuperior site using a leadless atrial pacemaker: A case series
- Open Access
- 9 January 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (1)
Cardiac Resynchronization Therapy: Reconsidering Its Essence as a Treatment for Electrical Dyssynchrony in Heart Failure
Cardiac resynchronization therapy (CRT) essentially targets electrical dyssynchrony, one of the key drivers in heart failure (HF). Its efficacy depends on both the quality (QRS morphology) and quantity (QRS duration) of dyssynchrony, requiring individualized patient selection. While drug therapy for HF has a limited effect on this substrate, early implantation of CRT can prevent irreversible remodeling and facilitate optimization of medical therapy. CRT should be recognized as an essential component within a comprehensive strategy for HF management in patients with appropriate indications.
- 9 January 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (1)
Open AccessCardiac Resynchronization Therapy: Reconsidering Its Essence as a Treatment for Electrical Dyssynchrony in Heart Failure
Cardiac resynchronization therapy (CRT) essentially targets electrical dyssynchrony, one of the key drivers in heart failure (HF). Its efficacy depends on both the quality (QRS morphology) and quantity (QRS duration) of dyssynchrony, requiring individualized patient selection. While drug therapy for HF has a limited effect on this substrate, early implantation of CRT can prevent irreversible remodeling and facilitate optimization of medical therapy. CRT should be recognized as an essential component within a comprehensive strategy for HF management in patients with appropriate indications.
- Open Access
- 26 April 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (5) , 557-565
Long-term outcomes of triple-site versus dual-site cardiac resynchronization therapy using temporary pacing to guide individualized implantation
- 26 April 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (5) , 557-565
Open AccessLong-term outcomes of triple-site versus dual-site cardiac resynchronization therapy using temporary pacing to guide individualized implantation
- 26 February 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (4) , 802-810
Delivery catheter system carries more physiological right ventricular septal pacing than stylet system
Introduction: The Mt. FUJI multicenter trial demonstrated that a delivery catheter system had a higher rate of successful right ventricular (RV) lead deployment on the RV septum (RVS) than a conventional stylet system. In this subanalysis of the Mt. FUJI trial, we assessed the differences in electrocardiogram (ECG) parameters during RV pacing between a delivery catheter system and a stylet system and their associations with the lead tip positions.Methods: Among 70 patients enrolled in the Mt FUJI trial, ECG parameters, RV lead tip positions, and lead depth inside the septum assessed by computed tomography were compared between the catheter group (n = 36) and stylet group (n = 34).Results: The paced QRS duration (QRS‐d), corrected paced QT (QTc), and JT interval (JTc) were significantly shorter in the catheter group than in the stylet group (QRS‐d: 130 ± 19 vs. 142 ± 15 ms, p = .004; QTc: 476 ± 25 vs. 514 ± 20 ms, p < .001; JTc: 347 ± 24 vs. 372 ± 17 ms, p < .001). This superiority of the catheter group was maintained in a subgroup analysis of patients with an RV lead tip position at the septum. The lead depth inside the septum was greater in the catheter group than in the stylet group, and there was a significant negative correlation between the paced QRS‐d and the lead depth.Conclusion: Using a delivery catheter system carries more physiological depolarization and repolarization during RVS pacing and deeper screw penetration in the septum in comparison to conventional stylet system. The lead depth could have a more impact on the ECG parameters rather than the type of pacing lead.
- 26 February 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (4) , 802-810
Delivery catheter system carries more physiological right ventricular septal pacing than stylet system
Introduction: The Mt. FUJI multicenter trial demonstrated that a delivery catheter system had a higher rate of successful right ventricular (RV) lead deployment on the RV septum (RVS) than a conventional stylet system. In this subanalysis of the Mt. FUJI trial, we assessed the differences in electrocardiogram (ECG) parameters during RV pacing between a delivery catheter system and a stylet system and their associations with the lead tip positions.Methods: Among 70 patients enrolled in the Mt FUJI trial, ECG parameters, RV lead tip positions, and lead depth inside the septum assessed by computed tomography were compared between the catheter group (n = 36) and stylet group (n = 34).Results: The paced QRS duration (QRS‐d), corrected paced QT (QTc), and JT interval (JTc) were significantly shorter in the catheter group than in the stylet group (QRS‐d: 130 ± 19 vs. 142 ± 15 ms, p = .004; QTc: 476 ± 25 vs. 514 ± 20 ms, p < .001; JTc: 347 ± 24 vs. 372 ± 17 ms, p < .001). This superiority of the catheter group was maintained in a subgroup analysis of patients with an RV lead tip position at the septum. The lead depth inside the septum was greater in the catheter group than in the stylet group, and there was a significant negative correlation between the paced QRS‐d and the lead depth.Conclusion: Using a delivery catheter system carries more physiological depolarization and repolarization during RVS pacing and deeper screw penetration in the septum in comparison to conventional stylet system. The lead depth could have a more impact on the ECG parameters rather than the type of pacing lead.
- Open Access
- 31 January 2024
- Published by Wiley
Improvement of the Quality of Life by Catheter Ablation for Atrial Fibrillation in Patients undergoing Hemodialysis
Introduction: Atrial fibrillation (AF) is the most common arrhythmia in patients undergoing hemodialysis (HD), which lowers the quality of life (QoL) and increases the risk of dialysis related complications. The present study aimed to evaluate the effectiveness of AF ablation on the QoL in patients undergoing HD. Methods and Results: Nineteen patients undergoing HD (14 men, age 68±8years, 15 paroxysmal AF) who underwent catheter ablation (CA) of drug-refractory AF were enrolled in the study. The ablation outcomes and procedural complications were evaluated and compared to 1053 consecutive patients without HD who underwent AF ablation. The Kidney Disease Quality of Life Short Form (KDQOL-SF) was assessed to evaluate the QoL of the HD patients at baseline and six months after the ablation. During the follow-up period of 17±13 months after the last procedure, the arrhythmia free rate was similar (HD patients 79% vs. non-HD patients 86%, log-rank p=0.82). There were no life-threatening complications in any patients. The KDQOL-SF of the HD patients six months after the ablation showed an improvement in the physical functioning (54±23 to 68±28, p<0.01), general health perceptions (38±17 to 48±15, p<0.01) and symptoms/problems (75±21 to 84±13, p=0.02) as compared to the baseline. Regarding the intradialytic symptoms, the dyspnea during HD significantly improved after the CA in the HD patients without AF recurrence (35% to 6%, p=0.04), while the atrial tachyarrhythmias and hypotension during HD remained unchanged. Conclusions: CA of AF improves the QoL in patients with chronic hemodialysis.
- 31 January 2024
- Published by Wiley
Open AccessImprovement of the Quality of Life by Catheter Ablation for Atrial Fibrillation in Patients undergoing Hemodialysis
Introduction: Atrial fibrillation (AF) is the most common arrhythmia in patients undergoing hemodialysis (HD), which lowers the quality of life (QoL) and increases the risk of dialysis related complications. The present study aimed to evaluate the effectiveness of AF ablation on the QoL in patients undergoing HD. Methods and Results: Nineteen patients undergoing HD (14 men, age 68±8years, 15 paroxysmal AF) who underwent catheter ablation (CA) of drug-refractory AF were enrolled in the study. The ablation outcomes and procedural complications were evaluated and compared to 1053 consecutive patients without HD who underwent AF ablation. The Kidney Disease Quality of Life Short Form (KDQOL-SF) was assessed to evaluate the QoL of the HD patients at baseline and six months after the ablation. During the follow-up period of 17±13 months after the last procedure, the arrhythmia free rate was similar (HD patients 79% vs. non-HD patients 86%, log-rank p=0.82). There were no life-threatening complications in any patients. The KDQOL-SF of the HD patients six months after the ablation showed an improvement in the physical functioning (54±23 to 68±28, p<0.01), general health perceptions (38±17 to 48±15, p<0.01) and symptoms/problems (75±21 to 84±13, p=0.02) as compared to the baseline. Regarding the intradialytic symptoms, the dyspnea during HD significantly improved after the CA in the HD patients without AF recurrence (35% to 6%, p=0.04), while the atrial tachyarrhythmias and hypotension during HD remained unchanged. Conclusions: CA of AF improves the QoL in patients with chronic hemodialysis.
- Open Access
- 14 July 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (9) , 1925-1932
Preferred left ventricular lead position for upgrade from right ventricular pacing to cardiac resynchronization therapy
Introduction: Cardiac resynchronization therapy (CRT) is well‐established for treating symptomatic heart failure with electrical dyssynchrony. The left ventricular (LV) lead position is recommended at LV posterolateral to lateral sites in patients with left bundle branch block; however, its preferred region remains unclear in patients being upgraded from right ventricular (RV) apical pacing to CRT. This study aimed to identify the preferred LV lead position for upgrading conventional RV apical pacing to CRT.Methods: We used electrode catheters positioned at the RV apex and LV anterolateral and posterolateral sites via the coronary sinus (CS) branches to measure the ratio of activation time to QRS duration from the RV apex to the LV anterolateral and posterolateral sites during RV apical pacing. Simultaneous biventricular pacing was performed at the RV apex and each LV site, and the differences in QRS duration and LV dP/dtmax from those of RV apical pacing were measured.Results: Thirty‐seven patients with anterolateral and posterolateral LV CS branches were included. During RV apical pacing, the average ratio of activation time to QRS duration was higher at the LV anterolateral site than at the LV posterolateral site (0.90 ± 0.06 vs. 0.71 ± 0.11, p < .001). The decreasing ratio of QRS duration and the increasing ratio of LV dP/dtmax were higher at the LV anterolateral site than at the posterolateral site (45.7 ± 18.0% vs. 32.0 ± 17.6%, p < .001; 12.7 ± 2.9% vs. 3.7 ± 8.2%, p < .001, respectively) during biventricular pacing compared with RV apical pacing.Conclusion: The LV anterolateral site is the preferred LV lead position in patients being upgraded from conventional RV apical pacing to CRT.
- 14 July 2023
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 34 (9) , 1925-1932
Open AccessPreferred left ventricular lead position for upgrade from right ventricular pacing to cardiac resynchronization therapy
Introduction: Cardiac resynchronization therapy (CRT) is well‐established for treating symptomatic heart failure with electrical dyssynchrony. The left ventricular (LV) lead position is recommended at LV posterolateral to lateral sites in patients with left bundle branch block; however, its preferred region remains unclear in patients being upgraded from right ventricular (RV) apical pacing to CRT. This study aimed to identify the preferred LV lead position for upgrading conventional RV apical pacing to CRT.Methods: We used electrode catheters positioned at the RV apex and LV anterolateral and posterolateral sites via the coronary sinus (CS) branches to measure the ratio of activation time to QRS duration from the RV apex to the LV anterolateral and posterolateral sites during RV apical pacing. Simultaneous biventricular pacing was performed at the RV apex and each LV site, and the differences in QRS duration and LV dP/dtmax from those of RV apical pacing were measured.Results: Thirty‐seven patients with anterolateral and posterolateral LV CS branches were included. During RV apical pacing, the average ratio of activation time to QRS duration was higher at the LV anterolateral site than at the LV posterolateral site (0.90 ± 0.06 vs. 0.71 ± 0.11, p < .001). The decreasing ratio of QRS duration and the increasing ratio of LV dP/dtmax were higher at the LV anterolateral site than at the posterolateral site (45.7 ± 18.0% vs. 32.0 ± 17.6%, p < .001; 12.7 ± 2.9% vs. 3.7 ± 8.2%, p < .001, respectively) during biventricular pacing compared with RV apical pacing.Conclusion: The LV anterolateral site is the preferred LV lead position in patients being upgraded from conventional RV apical pacing to CRT.
- Open Access
Preferred left ventricular lead position for upgrade from right ventricular pacing to cardiac resynchronization therapy
Background: Cardiac resynchronization therapy (CRT) is a well-established treatment for symptomatic heart failure with electrical dyssynchrony. The left ventricle (LV) lead position is recommended at LV posterolateral to lateral sites in patients with left bundle branch block; however, its preferred region remains unclear in patients upgrading from conventional right ventricular (RV) apical pacing to CRT. We aimed to identify the preferred LV lead position for upgrading conventional RV apical pacing to CRT. Methods: This study used electrode catheters positioned at the RV apex and LV anterolateral and posterolateral sites via the coronary sinus (CS) branches to measure the ratio of activation time to QRS duration from the RV apex to the LV anterolateral and LV posterolateral sites during RV apical pacing. We performed simultaneous biventricular pacing at the RV apex and each LV site and measured the differences in QRS duration and LV dP/dt max from those of RV apical pacing. Results: This study included 37 patients with anterolateral and posterolateral LV CS branches. During RV apical pacing, the average ratio of activation time to QRS duration was higher at the LV anterolateral site than at the LV posterolateral site (0.90±0.06 vs. 0.71±0.11, pmax were higher at the LV anterolateral site than at the LV posterolateral site (45.7±18.0% vs. 32.0±17.6%, p<0.001 and 12.7±2.9% vs. 3.7±8.2%, p<0.001, respectively) during biventricular pacing compared with those during RV apical pacing. Conclusions: The LV lead position is preferred at the LV anterolateral site in patients upgrading from conventional RV apical pacing to CRT. Condensed Pacing at the latest electrical activation site is crucial to improve electrical dyssynchrony in cardiac resynchronization therapy (CRT). However, the preferred location of the left ventricle (LV) lead position in patients upgrading from conventional right ventricular apical pacing to CRT is unclear. This study aimed to investigate proper strategies for CRT and identify an approach for patients upgrading to CRT. We showed that the preferred location is the LV anterolateral site. Our findings will help cardiologists and clinicians develop better strategies for treating patients with heart failure complicated with atrioventricular block.
Open AccessPreferred left ventricular lead position for upgrade from right ventricular pacing to cardiac resynchronization therapy
Background: Cardiac resynchronization therapy (CRT) is a well-established treatment for symptomatic heart failure with electrical dyssynchrony. The left ventricle (LV) lead position is recommended at LV posterolateral to lateral sites in patients with left bundle branch block; however, its preferred region remains unclear in patients upgrading from conventional right ventricular (RV) apical pacing to CRT. We aimed to identify the preferred LV lead position for upgrading conventional RV apical pacing to CRT. Methods: This study used electrode catheters positioned at the RV apex and LV anterolateral and posterolateral sites via the coronary sinus (CS) branches to measure the ratio of activation time to QRS duration from the RV apex to the LV anterolateral and LV posterolateral sites during RV apical pacing. We performed simultaneous biventricular pacing at the RV apex and each LV site and measured the differences in QRS duration and LV dP/dt max from those of RV apical pacing. Results: This study included 37 patients with anterolateral and posterolateral LV CS branches. During RV apical pacing, the average ratio of activation time to QRS duration was higher at the LV anterolateral site than at the LV posterolateral site (0.90±0.06 vs. 0.71±0.11, pmax were higher at the LV anterolateral site than at the LV posterolateral site (45.7±18.0% vs. 32.0±17.6%, p<0.001 and 12.7±2.9% vs. 3.7±8.2%, p<0.001, respectively) during biventricular pacing compared with those during RV apical pacing. Conclusions: The LV lead position is preferred at the LV anterolateral site in patients upgrading from conventional RV apical pacing to CRT. Condensed Pacing at the latest electrical activation site is crucial to improve electrical dyssynchrony in cardiac resynchronization therapy (CRT). However, the preferred location of the left ventricle (LV) lead position in patients upgrading from conventional right ventricular apical pacing to CRT is unclear. This study aimed to investigate proper strategies for CRT and identify an approach for patients upgrading to CRT. We showed that the preferred location is the LV anterolateral site. Our findings will help cardiologists and clinicians develop better strategies for treating patients with heart failure complicated with atrioventricular block.
- Open Access
- 16 February 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (4) , 1451-1457
Usefulness of delivery catheter on accurate right ventricular septal pacing: Mt FUJI trial
Although the delivery catheter system for pacemaker-lead implantation is a new alternative to the stylet system, no randomized controlled trial has addressed the difference in right ventricular (RV) lead placement accuracy to the septum between the stylet and the delivery catheter systems. This multicentre prospective randomized controlled trial aimed to prove the efficacy of the delivery catheter system for accurate delivery of RV lead to the septum. In this trial, 70 patients (mean age 78 ± 11 years; 30 men) with pacemaker indications of atrioventricular block were randomized to the delivery catheter or the stylet groups. Right ventricular lead tip positions were assessed using cardiac computed tomography within 4 weeks of pacemaker implantation. Lead tip positions were classified into RV septum, anterior/posterior edge of the RV septal wall, and RV free wall. The primary endpoint was the success rate of RV lead tip placement to the RV septum. Right ventricular leads were implanted as per allocation in all patients. The delivery catheter group had higher success rate of RV lead deployment to the septum (78 vs. 50%; P = 0.024) and narrower paced QRS width (130 ± 19 vs. 142 ± 15 ms P = 0.004) than those in the stylet group. However, there was no significant difference in procedure time [91 (IQR 68–119) vs. 85 (59–118) min; P = 0.488] or the incidence of RV lead dislodgment (0 vs. 3%; P = 0.486). The delivery catheter system can achieve a higher success rate of RV lead placement to the RV septum and narrower paced QRS width than the stylet system. jRCTs042200014 (https://jrct.niph.go.jp/en-latest-detail/jRCTs042200014) Outcome comparison between delivery catheter and stylet systems. The delivery catheter system can achieve a higher RV lead placement on the RV septum success rate and a narrower paced QRS width than the stylet system. RV, right ventricular.
- 16 February 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (4) , 1451-1457
Open AccessUsefulness of delivery catheter on accurate right ventricular septal pacing: Mt FUJI trial
Although the delivery catheter system for pacemaker-lead implantation is a new alternative to the stylet system, no randomized controlled trial has addressed the difference in right ventricular (RV) lead placement accuracy to the septum between the stylet and the delivery catheter systems. This multicentre prospective randomized controlled trial aimed to prove the efficacy of the delivery catheter system for accurate delivery of RV lead to the septum. In this trial, 70 patients (mean age 78 ± 11 years; 30 men) with pacemaker indications of atrioventricular block were randomized to the delivery catheter or the stylet groups. Right ventricular lead tip positions were assessed using cardiac computed tomography within 4 weeks of pacemaker implantation. Lead tip positions were classified into RV septum, anterior/posterior edge of the RV septal wall, and RV free wall. The primary endpoint was the success rate of RV lead tip placement to the RV septum. Right ventricular leads were implanted as per allocation in all patients. The delivery catheter group had higher success rate of RV lead deployment to the septum (78 vs. 50%; P = 0.024) and narrower paced QRS width (130 ± 19 vs. 142 ± 15 ms P = 0.004) than those in the stylet group. However, there was no significant difference in procedure time [91 (IQR 68–119) vs. 85 (59–118) min; P = 0.488] or the incidence of RV lead dislodgment (0 vs. 3%; P = 0.486). The delivery catheter system can achieve a higher success rate of RV lead placement to the RV septum and narrower paced QRS width than the stylet system. jRCTs042200014 (https://jrct.niph.go.jp/en-latest-detail/jRCTs042200014) Outcome comparison between delivery catheter and stylet systems. The delivery catheter system can achieve a higher RV lead placement on the RV septum success rate and a narrower paced QRS width than the stylet system. RV, right ventricular.